NO932120L - Biphenyl derivatives, drugs containing them, and methods for their preparation - Google Patents

Biphenyl derivatives, drugs containing them, and methods for their preparation

Info

Publication number
NO932120L
NO932120L NO932120A NO932120A NO932120L NO 932120 L NO932120 L NO 932120L NO 932120 A NO932120 A NO 932120A NO 932120 A NO932120 A NO 932120A NO 932120 L NO932120 L NO 932120L
Authority
NO
Norway
Prior art keywords
preparation
drugs containing
biphenyl derivatives
methods
salts
Prior art date
Application number
NO932120A
Other languages
Norwegian (no)
Other versions
NO932120D0 (en
Inventor
Helmut Pieper
Frank Himmelsbach
Guenter Linz
Volkhard Austel
Thomas Mueller
Johannes Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO932120D0 publication Critical patent/NO932120D0/en
Publication of NO932120L publication Critical patent/NO932120L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Oppfinnelsen angår bifenylderivater med den generelle formel (I) hvor A til E og x er som definert i patentkrav l, deres stereoisomerer, innbefattet deres blandinger og deres salter, spesielt deres fysiologisk akseptable salter med uorganiske eller organiske syrer som oppviser verdifulle egenskaper, fortrinnsvis aggregasjonshemmende virkninger, legemidler som inneholder disse forbindelsene og fremgangs- måter for deres fremstilling.The invention relates to biphenyl derivatives of the general formula (I) wherein A to E and x are as defined in claim 1, their stereoisomers, including their mixtures and their salts, in particular their physiologically acceptable salts with inorganic or organic acids which exhibit valuable properties, preferably aggregation inhibitors. effects, drugs containing these compounds and procedures for their preparation.

NO932120A 1992-06-11 1993-06-10 Biphenyl derivatives, drugs containing them, and methods for their preparation NO932120L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4219158A DE4219158A1 (en) 1992-06-11 1992-06-11 Biphenyl derivatives, pharmaceutical compositions containing them and processes for their preparation

Publications (2)

Publication Number Publication Date
NO932120D0 NO932120D0 (en) 1993-06-10
NO932120L true NO932120L (en) 1993-12-13

Family

ID=6460811

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932120A NO932120L (en) 1992-06-11 1993-06-10 Biphenyl derivatives, drugs containing them, and methods for their preparation

Country Status (14)

Country Link
EP (1) EP0574808A1 (en)
JP (1) JPH0673038A (en)
KR (1) KR940005554A (en)
CN (1) CN1080917A (en)
AU (1) AU4120193A (en)
CA (1) CA2098158A1 (en)
DE (1) DE4219158A1 (en)
FI (1) FI932649A7 (en)
HU (1) HU9301700D0 (en)
IL (1) IL105976A0 (en)
MX (1) MX9303466A (en)
NO (1) NO932120L (en)
PL (1) PL299260A1 (en)
ZA (1) ZA934090B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0691959B1 (en) * 1993-03-29 1998-07-22 Zeneca Limited Heterocyclic derivatives as platelet aggregation inhibitors
US5652242A (en) * 1993-03-29 1997-07-29 Zeneca Limited Heterocyclic derivatives
US5750754A (en) * 1993-03-29 1998-05-12 Zeneca Limited Heterocyclic compounds
US5753659A (en) * 1993-03-29 1998-05-19 Zeneca Limited Heterocyclic compouds
EP0690847A1 (en) * 1993-03-29 1996-01-10 Zeneca Limited Heterocyclic compounds as platelet aggregation inhibitors
GB9313268D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Chemical compounds
GB9313285D0 (en) * 1993-06-28 1993-08-11 Zeneca Ltd Acid derivatives
US5463011A (en) * 1993-06-28 1995-10-31 Zeneca Limited Acid derivatives
DE4424974A1 (en) * 1994-07-15 1996-01-18 Thomae Gmbh Dr K Urea and carbamic acid derivatives, medicaments containing these compounds and process for their preparation
DE19636689A1 (en) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg New benzamidine derivatives
UA52797C2 (en) * 1997-11-20 2003-01-15 Тейдзін Лімітед Biphenylamidine derivatives
DE19819548A1 (en) 1998-04-30 1999-11-04 Merck Patent Gmbh Biphenyl derivatives
AU2868601A (en) * 2000-01-27 2001-08-07 Ribotargets Ltd Biaryl compounds, their preparation and their use in therapy
US7534894B2 (en) 2003-09-25 2009-05-19 Wyeth Biphenyloxy-acids
ATE502025T1 (en) * 2004-10-19 2011-04-15 Compass Pharmaceuticals Llc ARYLCARBOXAMIDES AND THEIR USE AS ANTI-TUMOR AGENTS
BRPI0713350B1 (en) 2006-06-26 2022-04-12 Akebia Therapeutics Inc Compound and Composition
EP2717870B1 (en) 2011-06-06 2017-09-27 Akebia Therapeutics Inc. Composition for stabilizing hypoxia inducible factor-2 alpha useful for treating cancer
NO2686520T3 (en) 2011-06-06 2018-03-17
SG10201910773VA (en) 2013-06-13 2020-01-30 Akebia Therapeutics Inc Compositions and methods for treating anemia
AR099354A1 (en) 2013-11-15 2016-07-20 Akebia Therapeutics Inc SOLID FORMS OF ACID {[5- (3-CHLOROPHENYL) -3-HYDROXIPIRIDIN-2-CARBON] AMINO} ACETIC, COMPOSITIONS, AND ITS USES
AU2016209126A1 (en) 2015-01-23 2017-08-10 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
US11324734B2 (en) 2015-04-01 2022-05-10 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
EP3790863A1 (en) 2018-05-09 2021-03-17 Akebia Therapeutics Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
DE4035961A1 (en) * 1990-11-02 1992-05-07 Thomae Gmbh Dr K CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
DE4102024A1 (en) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K BIPHENYL DERIVATIVES, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND METHOD FOR THE PRODUCTION THEREOF
DK0518819T3 (en) * 1991-06-11 1995-09-25 Ciba Geigy Ag Amidino compounds, their preparation and use as a drug
DE4127404A1 (en) * 1991-08-19 1993-02-25 Thomae Gmbh Dr K CYCLIC IMINODERIVATES, MEDICAMENTS CONTAINING SUCH COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
CA2098158A1 (en) 1993-12-12
KR940005554A (en) 1994-03-21
PL299260A1 (en) 1994-03-07
FI932649L (en) 1993-12-12
AU4120193A (en) 1993-12-23
MX9303466A (en) 1994-01-31
FI932649A0 (en) 1993-06-10
JPH0673038A (en) 1994-03-15
DE4219158A1 (en) 1993-12-16
EP0574808A1 (en) 1993-12-22
CN1080917A (en) 1994-01-19
HU9301700D0 (en) 1993-09-28
NO932120D0 (en) 1993-06-10
ZA934090B (en) 1994-12-11
FI932649A7 (en) 1993-12-12
IL105976A0 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
NO932120L (en) Biphenyl derivatives, drugs containing them, and methods for their preparation
NO934501L (en) Carboxylic acid derivatives, drugs containing these compounds, and process for their preparation
NO920957L (en) CYCLE URINARY DERIVATIVES AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS
NO933248L (en) Cyclic urea derivatives, drugs containing these compounds, and process for their preparation
NO972881L (en) Piperazine derivatives, drugs containing them, their use and methods for their preparation
NO922940L (en) FIVE-JOINT HETEROCYCLIC COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM
NO923466L (en) Heterocyclic Compounds with 5 Sections, PROCEDURE PREPARATION, AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS
DK0496378T3 (en) Biphenyl derivatives, drugs containing these compounds and methods for their preparation
NO940261L (en) 5-membered heterocycles, process for the preparation thereof and drugs containing these compounds
NO923235L (en) CYCLIC IMINO DERIVATIVES, AND PROCEDURES FOR PREPARING SUCH THINGS.
DK0483667T3 (en) Cyclic imino derivatives, drugs containing these compounds and processes for their preparation
MX9803954A (en) Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them.
NO931526L (en) CYCLIC IMINO DERIVATIVES, PROCEDURES FOR THEIR PREPARATION, AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
NO914356L (en) MONO N-SUBSTITUTED 1,4,7,10-TETRAAZACYCLODODE CANDY DERIVATIVES, PROCEDURES FOR THE PREPARATION OF THEM, AND PHARMACEUTICALS CONTAINING THEM
MX9401315A (en) CYCLIC DERIVATIVES, MEDICINES CONTAINING THESE COMPOUNDS AND PROCEDURE FOR THEIR PREPARATION.
NO20052496L (en) Selected CGRP antagonists, methods for their preparation and use thereof as drugs.
RU94042907A (en) Imidazopyridine derivatives, method of their synthesis, pharmaceutical composition and method of its preparing
NO20023161L (en) Substituted piperidines, drugs containing these compounds and processes for their preparation
NO931527L (en) CYCLIC IMINO DERIVATIVES, MEDICINAL PREPARATIONS CONTAINING THESE, AND PROCEDURE FOR THEIR PREPARATION
NO940524L (en)
NO971625L (en) Novel peptides with immunomodulatory effects
NO308607B1 (en) Chemical compound, a pharmaceutical composition containing it, and the use of the compound for the preparation of a platelet aggregation inhibitor and the preparation of a pharmaceutical composition for the treatment or prevention of thrombotic
NO931342L (en) BENZIMIDAZOLES, MEDICAL PREPARATIONS CONTAINING THESE, AND PROCEDURES FOR THEIR PREPARATION
ATE63563T1 (en) SYNERGIST DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM.
NO932722L (en) SALTS OF A 4-AMINO-3ACYL-QUINOLINE DERIVATIVE AND THEIR USE AS INHIBATORS FOR GASTRIC ACID SECRETION